{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,18]],"date-time":"2026-04-18T21:51:18Z","timestamp":1776549078295,"version":"3.51.2"},"reference-count":58,"publisher":"Public Library of Science (PLoS)","issue":"5","license":[{"start":{"date-parts":[[2019,5,29]],"date-time":"2019-05-29T00:00:00Z","timestamp":1559088000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0216935","type":"journal-article","created":{"date-parts":[[2019,5,29]],"date-time":"2019-05-29T17:29:36Z","timestamp":1559150976000},"page":"e0216935","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":35,"title":["Yttrium-90 trans-arterial radioembolization in advanced-stage HCC: The impact of portal vein thrombosis on survival"],"prefix":"10.1371","volume":"14","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8193-3050","authenticated-orcid":true,"given":"Francesco","family":"Somma","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vincenzo","family":"Stoia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nicola","family":"Serra","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Roberto","family":"D\u2019Angelo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gianluca","family":"Gatta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francesco","family":"Fiore","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2019,5,29]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"74","DOI":"10.3322\/canjclin.55.2.74","article-title":"Global cancer statistics, 2002","volume":"55","author":"DM Parkin","year":"2005","journal-title":"CA Cancer J Clin"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1159\/000444394","article-title":"A Hepatocellular Carcinoma Aggressiveness Index and Its Relationship to Liver Enzyme Levels","volume":"90","author":"BI Carr","year":"2016","journal-title":"Oncology"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1002\/hep.510290145","article-title":"Natural history of untreated nonsurgical hepatocellular carcinoma: rationale for the design and evaluation of therapeutic trials","volume":"29","author":"JM Llovet","year":"1999","journal-title":"Hepatology"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1007\/s004320050189","article-title":"Portal vein thrombosis in hepatocellular carcinoma: age and sex distribution in an autopsy study","volume":"124","author":"M Pirisi","year":"1998","journal-title":"J Cancer Res Clin Oncol"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1159\/000348325","article-title":"Treatment for hepatocellular carcinoma with portal vein tumor thrombosis: the emerging role for radioembolization using yttrium-90","volume":"84","author":"WY Lau","year":"2013","journal-title":"Oncology"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1200\/JCO.2006.09.8657","article-title":"Transcatheter and ablative therapeutic approaches for solid malignancies","volume":"25","author":"E Liapi","year":"2007","journal-title":"J Clin Oncol"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"1907","DOI":"10.1016\/S0140-6736(03)14964-1","article-title":"Hepatocellular carcinoma","volume":"362","author":"JM Llovet","year":"2003","journal-title":"Lancet"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1097\/00000658-199403000-00003","article-title":"Current treatment modalities for hepatocellular carcinoma","volume":"219","author":"DG Famer","year":"1994","journal-title":"Ann Surg"},{"key":"ref9","first-page":"969","article-title":"The blood supply of neoplasms in the liver","volume":"30","author":"C Breedis","year":"1954","journal-title":"Am J Pathol"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1148\/radiol.2241011262","article-title":"Transarterial chemoembolization for unresectable hepatocellular carcinoma: meta-analysis of randomized controlled trials","volume":"224","author":"C Camma","year":"2002","journal-title":"Radiology"},{"issue":"8","key":"ref11","doi-asserted-by":"crossref","first-page":"1920","DOI":"10.1111\/j.1600-6143.2009.02695.x","article-title":"A comparative analysis of transarterial downstaging for hepatocellular carcinoma: chemoembolization versus radioembolization","volume":"9","author":"RJ Lewandowski","year":"2009","journal-title":"Am J Transplant"},{"issue":"6","key":"ref12","doi-asserted-by":"crossref","first-page":"e0129573","DOI":"10.1371\/journal.pone.0129573","article-title":"Use of Ethanol in the Trans-Arterial Lipiodol Embolization (TAELE) of Intermediated-Stage HCC: Is This Safer than Conventional Trans-Arterial Chemo-Embolization (c-TACE)?","volume":"10","author":"F Somma","year":"2015","journal-title":"PLoS One"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.1097\/01.RVI.0000233785.75257.9A","article-title":"Radioembolization with 90Yttrium microspheres: A state-of-the-art brachytherapy treatment for primary and secondary liver malignancies: Part 1: Technical and methodologic considerations","volume":"17","author":"R Salem","year":"2006","journal-title":"J Vasc Interv Radiol"},{"issue":"7","key":"ref14","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1097\/01.RVI.0000164324.79242.B2","article-title":"Angiographic considerations in patients undergoing liver-directed therapy","volume":"16","author":"DM Liu","year":"2005","journal-title":"J Vasc Interv Radiol"},{"issue":"4","key":"ref15","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1007\/s00270-007-9064-z","article-title":"Radioembolization with 90Y microspheres: angiographic and technical considerations","volume":"30","author":"RJ Lewandowski","year":"2007","journal-title":"Cardiovasc Intervent Radiol"},{"issue":"1","key":"ref16","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1053\/j.tvir.2007.08.001","article-title":"Technical aspects of radioembolization with 90Y microspheres","volume":"10","author":"R Salem","year":"2007","journal-title":"Tech Vasc Interv Radiol"},{"issue":"9","key":"ref17","doi-asserted-by":"crossref","first-page":"S223","DOI":"10.1016\/S1051-0443(07)61790-4","article-title":"Yttrium-90 microspheres: radiation therapy for unresectable liver cancer","volume":"13","author":"R Salem","year":"2002","journal-title":"J Vasc Interv Radiol"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1259\/bjr.70.836.9486047","article-title":"Tumor-to-normal uptake ratio of 90Y microspheres in hepatic cancer assessed with 99Tcm macroaggregated albumin","volume":"70","author":"S Ho","year":"1997","journal-title":"Br J Radiol"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1007\/BF01084369","article-title":"Partition model for estimating radiation doses from yttrium-90 microspheres in treating hepatic tumors","volume":"23","author":"S Ho","year":"1996","journal-title":"Eur J Nucl Med"},{"issue":"1","key":"ref20","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1055\/s-0030-1247132","article-title":"Modified RECIST (mRECIST) Assessment for Hepatocellular Carcinoma","volume":"30","author":"R Lencioni","year":"2010","journal-title":"Semin Liver Dis"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1016\/j.jhep.2011.12.001","article-title":"EASL-EORTC clinical practice guidelines: management of hepatocellular carcinoma","volume":"56","year":"2012","journal-title":"J Hepatol"},{"issue":"11","key":"ref22","first-page":"1325","article-title":"Hepatocellular carcinoma: initial tumor response after short-term and long-interval chemoembolization with drug-eluting beads using modified RECIST","volume":"24","author":"R Syha","year":"2012","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"ref23","article-title":"Transarterial embolization (TAE) is equally effective and slightly safer than transarterial chemoembolization (TACE) to manage liver metastases in neuroendocrine tumors","author":"F Fiore","year":"2014","journal-title":"Endocrine"},{"key":"ref24","first-page":"724","author":"R.R Sokal","year":"1995"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1080\/01621459.1958.10501452","article-title":"Nonparametric estimation from incomplete observations","volume":"53","author":"EL Kaplan","year":"1958","journal-title":"J Am. Stat. Assoc"},{"key":"ref26","first-page":"e 146","article-title":"Statistical models in Epidemiology.","volume":"27\u201336","author":"D Clayton","year":"1993"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1056\/NEJM199603143341104","article-title":"Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis","volume":"334","author":"V Mazzaferro","year":"1996","journal-title":"N Engl J Med"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1097\/01.sla.0000109022.32391.eb","article-title":"Adult living donor liver transplantation for patients with hepatocellular carcinoma: extending UNOS priority criteria","volume":"239","author":"GE Gondolesi","year":"2004","journal-title":"Ann Surg"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"2073","DOI":"10.1245\/s10434-010-0940-4","article-title":"Surgical treatment of hepatocellular carcinoma with portal vein tumor thrombus","volume":"17","author":"J Shi","year":"2010","journal-title":"Ann Surg Oncol"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1148\/radiol.2343040350","article-title":"Early-stage hepatocellular carcinoma in patients with cirrhosis: long-term results of percutaneous image-guided radiofrequency ablation","volume":"234","author":"R Lencioni","year":"2005","journal-title":"Radiology"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1002\/hep.510280322","article-title":"A new prognostic system for hepatocellular carcinoma: a retrospective study of 435 patients: the Cancer of the Liver Italian Program (CLIP) investigators","volume":"28","year":"1998","journal-title":"Hepatology"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"1208","DOI":"10.1002\/hep.20933","article-title":"Management of hepatocellular carcinoma","volume":"42","author":"J Bruix","year":"2005","journal-title":"Hepatology"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1056\/NEJMoa0708857","article-title":"Sorafenib in advanced hepatocellular carcinoma","volume":"359","author":"JM Llovet","year":"2008","journal-title":"N Engl J Med"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/S1470-2045(08)70285-7","article-title":"Efficacy and safety of sorafenib in patients in the Asia-Pacific region with advanced hepatocellular carcinoma: a phase III randomised, double-blind, placebo-controlled trial","volume":"10","author":"AL Cheng","year":"2009","journal-title":"Lancet Oncol"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1016\/j.jhep.2012.06.014","article-title":"Efficacy and safety of sorafenib in patients with advanced hepatocellular carcinoma: subanalyses of a phase III trial","volume":"57","author":"J Bruix","year":"2012","journal-title":"J Hepatol"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/S1470-2045(08)70285-7","article-title":"Efficacy and safety of sorafenib in patients in the Asia-Pacific region with advanced hepatocellular carcinoma: a phase III randomised, double-blind, placebo-controlled trial","volume":"10","author":"AL Cheng","year":"2009","journal-title":"Lancet Oncol"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"791013","DOI":"10.4061\/2011\/791013","article-title":"Liver resection after downstaging hepatocellular carcinoma with sorafenib","volume":"2011","author":"L Barbier","year":"2011","journal-title":"Int J Hepatol"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"696","DOI":"10.5009\/gnl.2013.7.6.696","article-title":"Practical effect of sorafenib monotherapy on advanced hepatocellular carcinoma and portal vein tumor thrombosis","volume":"7","author":"SW Jeong","year":"2013","journal-title":"Gut Liver"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"1734","DOI":"10.1016\/S0140-6736(02)08649-X","article-title":"Arterial embolisation orchemoembolisation versus symptomatic treatment in patients with unresectable hepatocellular carcinoma: a randomised controlled trial","volume":"359","author":"JM Llovet","year":"2002","journal-title":"Lancet"},{"key":"ref40","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1148\/radiol.10091473","article-title":"Chemoembolization for hepatocellular carcinoma: comprehensive imaging and survival analysis in a 172-patient cohort","volume":"255","author":"RJ Lewandowski","year":"2010","journal-title":"Radiology"},{"key":"ref41","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1093\/jnci\/djn134","article-title":"Design and endpoints of clinical trials in hepatocellular carcinoma","volume":"100","author":"JM Llovet","year":"2008","journal-title":"J Natl Cancer Inst"},{"key":"ref42","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1007\/s00270-009-9711-7","article-title":"Prospective Randomized Study of Doxorubicin-Eluting-Bead Embolization in the Treatment of Hepatocellular Carcinoma: Results of the PRECISION V Study","volume":"33","author":"J Lammer","year":"2010","journal-title":"Cardiovasc Intervent Radiol"},{"key":"ref43","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1148\/radiol.12111550","article-title":"Advanced-stage hepatocellular carcinoma: transarterial chemoembolization versus sorafenib","volume":"263","author":"M Pinter","year":"2012","journal-title":"Radiology"},{"key":"ref44","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1148\/radiol.10101058","article-title":"Transarterial chemoembolization can be safely performed in patients with hepatocellular carcinoma invading the main portal vein and may improve the overall survival","volume":"258","author":"GE Chung","year":"2011","journal-title":"Radiology"},{"key":"ref45","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1245\/s10434-010-1321-8","article-title":"Transarterial chemoembolization for unresectable hepatocellular carcinoma with portal vein tumor thrombosis: a prospective comparative study","volume":"18","author":"J Luo","year":"2011","journal-title":"Ann Surg Oncol"},{"key":"ref46","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.3892\/mco.2014.391","article-title":"Transarterial chemoembolization vs. conservative treatment for unresectable infiltrating hepatocellular carcinoma: A retrospective comparative study","volume":"2","author":"QS Dai","year":"2014","journal-title":"Mol Clin Oncol"},{"key":"ref47","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1007\/s00270-005-0171-4","article-title":"Treatment of unresectable primary and metastatic liver cancer with yttrium-90 microspheres (TheraSphere): assessment of hepatic arterial embolization","volume":"29","author":"K Sato","year":"2006","journal-title":"Cardiovasc Intervent Radiol"},{"key":"ref48","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1016\/j.ijrobp.2005.12.051","article-title":"Resin 90Ymicrosphere brachytherapy for unresectable colorectal liver metastases: modern USA experience","volume":"65","author":"AS Kennedy","year":"2006","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"ref49","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1016\/j.jhep.2011.07.012","article-title":"Radioembolization for hepatocellular carcinoma","volume":"56","author":"B Sangro","year":"2012","journal-title":"J Hepatol"},{"key":"ref50","doi-asserted-by":"crossref","first-page":"S63","DOI":"10.1016\/S0168-8278(17)30436-1","article-title":"SARAH: a randomised controlled trial comparing efficacy and safety of selective internal radiation therapy (with yttrium-90 microspheres) and sorafenib in patients with locally advanced hepatocellular carcinoma","volume":"66","author":"V Vilgrain","year":"2017","journal-title":"J Hepatol"},{"key":"ref51","article-title":"Asia-Pacific Hepatocellular Carcinoma Trials Group: Phase III multi-centre open-label randomized controlled trial of selective internal radiation therapy (SIRT) versus sorafenib in locally advanced hepatocellular carcinoma: The SIRveNIB study","volume":"35","author":"PHW Chow","year":"2017","journal-title":"J Clin Oncol"},{"key":"ref52","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1159\/000481315","article-title":"Hepatocellular Carcinoma with Macrovascular Invasion: Defining the Optimal Treatment Strategy","volume":"6","author":"CE Costentin","year":"2017","journal-title":"Liver Cancer"},{"key":"ref53","first-page":"1683","article-title":"A retrospective comparative analysis of the effect of Y90-radioembolization on the survival of patients with unresectable hepatocellular carcinoma","volume":"56","author":"D D\u2019Avola","year":"2009","journal-title":"Hepatogastroenterology"},{"key":"ref54","doi-asserted-by":"crossref","first-page":"1741","DOI":"10.1002\/hep.23944","article-title":"Radioembolization with yttrium-90 glass microspheres in hepatocellular carcinoma: European experience on safety and longterm survival","volume":"52","author":"P Hilgard","year":"2010","journal-title":"Hepatology"},{"key":"ref55","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1053\/j.gastro.2009.09.006","article-title":"Radioembolization for hepatocellular carcinoma using Yttrium-90 microspheres: a comprehensive report of long-term outcomes","volume":"138","author":"R Salem","year":"2010","journal-title":"Gastroenterology"},{"key":"ref56","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1002\/hep.24451","article-title":"Survival after yttrium-90 resin microsphere radioembolization of hepatocellular carcinoma across Barcelona clinic liver cancer stages: a European evaluation","volume":"54","author":"B Sangro","year":"2011","journal-title":"Hepatology"},{"key":"ref57","doi-asserted-by":"crossref","first-page":"1826","DOI":"10.1002\/hep.26014","article-title":"Yttrium-90 radioembolization for intermediate-advanced hepatocellular carcinoma: a phase 2 study","volume":"57","author":"V Mazzaferro","year":"2013","journal-title":"Hepatology"},{"issue":"3","key":"ref58","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1007\/s11864-012-0200-x","article-title":"Chemoembolization and radioembolization for metastatic disease to the liver: available data and future studies","volume":"13","author":"K Memon","year":"2012","journal-title":"Curr Treat Options Oncol"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0216935","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,9]],"date-time":"2020-05-09T04:01:14Z","timestamp":1588996874000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0216935"}},"subtitle":[],"editor":[{"given":"Gayle E.","family":"Woloschak","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2019,5,29]]},"references-count":58,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2019,5,29]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0216935","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,5,29]]}}}